Drug Guide
Corticotropin (H.P. Acthar Gel)
Classification
Therapeutic: Anti-inflammatory, Immunosuppressant
Pharmacological: Adrenocorticotropic hormone (ACTH) analogue
FDA Approved Indications
- Multiple sclerosis relapses, including those associated with neuro-Behçet's syndrome
- Infantile spasms (West syndrome)
- Alzheimer's disease (off-label)
- Multiple other inflammatory conditions
Mechanism of Action
Stimulates the adrenal cortex to secrete corticosteroids and adrenal hormones, thereby exerting anti-inflammatory and immunomodulatory effects.
Dosage and Administration
Adult: Dosage varies depending on condition; for infantile spasms, typically 20-40 units subcutaneously or intramuscularly daily for 2-4 weeks.
Pediatric: Dose as per condition; for infantile spasms, 20-40 units daily for 2 weeks.
Geriatric: Adjustment may be necessary based on response and comorbidities.
Renal Impairment: No specific adjustment; monitor closely.
Hepatic Impairment: No specific adjustment noted.
Pharmacokinetics
Absorption: Well absorbed after IM or subcutaneous injection.
Distribution: Widely distributed; specific volume not established.
Metabolism: Metabolized via hepatic pathways; metabolites eliminated by renal and hepatic routes.
Excretion: Metabolites excreted primarily in urine.
Half Life: Approximately 1-3 hours.
Contraindications
- Hypersensitivity to corticotropin or synthetic adrenocorticotropic hormones.
- Active systemic infections.
Precautions
- Use with caution in patients with existing infections, osteoporosis, or psychiatric conditions. Monitor for signs of adrenal suppression with prolonged use. Pregnancy category C; benefit-risk assessment needed. Consider lactation implications.
Adverse Reactions - Common
- Injection site reactions (Common)
- Fluid retention, edema (Common)
- Hypertension (Common)
Adverse Reactions - Serious
- Infections due to immunosuppression (Serious)
- Severe allergic reactions (Rare)
- Cushingoid features (Uncommon)
Drug-Drug Interactions
- Potent CYP3A4 inhibitors (e.g., ketoconazole) may increase corticosteroid effects.
- Vaccines: Live vaccines may pose risk during therapy.
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor for allergic reactions, signs of infection, electrolyte imbalance, blood pressure, blood glucose levels.
Diagnoses:
- Risk of infection related to immunosuppression
- Fluid volume excess related to corticosteroid effects
Implementation: Administer as prescribed, monitor vital signs, blood glucose, electrolytes, and signs of adverse effects.
Evaluation: Assess therapeutic response and adverse effects regularly to adjust treatment accordingly.
Patient/Family Teaching
- Report signs of infection promptly.
- Do not stop medication abruptly.
- Monitor blood glucose if diabetic.
- Follow up on scheduled laboratory tests.
Special Considerations
Black Box Warnings:
- Long-term use may lead to adrenal suppression, osteoporosis, and other corticosteroid-related side effects.
- Use caution in patients with infections.
Genetic Factors: Genetic variations may influence metabolism and response.
Lab Test Interference: May cause increased cortisol levels in laboratory tests, affecting diagnostic assessments.
Overdose Management
Signs/Symptoms: Symptoms of adrenal suppression or corticosteroid excess, such as hyperglycemia, hypertension, or infection.
Treatment: Discontinue drug immediately, provide supportive care, and monitor vital signs and laboratory parameters.
Storage and Handling
Storage: Store at 2-8°C (36-46°F). Do not freeze.
Stability: Stable until expiration date when stored properly.